等待开盘 11-07 09:30:00 美东时间
-0.640
-5.95%
Viatris shares are trading lower after the company reported Q3 financial result...
今天 01:08
Viatris (NASDAQ:VTRS) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.62 by 7.89 percent. This is a 10.67 percent decrease over earnings of $0.75 per share from the same
11-06 20:04
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Lexicon Pharmaceuticals reported Q3 2025 financial results with total revenue increasing to $14.2M, driven by $13.2M in licensing revenue from the Novo Nordisk agreement. R&D expenses decreased to $18.8M, while SG&A expenses fell to $7.6M. The company achieved a net loss of $12.8M compared to $64.8M in Q3 2024. Key milestones include scheduling an End-of-Phase 2 meeting for pilavapadin, completing LX9851 IND-enabling studies, advancing sotagliflo...
11-06 12:30
Teva Q3 revenue rose to $4.48 billion, beating estimates, as Austedo and Ajovy boosted growth; 2025 EPS outlook now $2.55–$2.65.
11-06 00:30
PITTSBURGH, Nov. 4, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on November 3, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for eac...
11-04 19:59
The U.S. FDA on Wednesday issued draft guidance that aims to accelerate the process for getting biosimilar drugs -- essentially generic versions of pricey biologic-based medicines -- to consumers. The...
10-30 03:56
The latest announcement is out from Viatris ( ($VTRS) ). On October 24, 2025, V...
10-25 04:45
The Trump administration is preparing to launch a new investigation under Section 301 of the Trade Act of 1974 to determine whether U.S. trading partners are underpaying for prescription drugs, potent...
10-22 17:26
Analysts are intrested in these 5 stocks: ( ($GM) ), ( ($NVDA) ), ( ($VTRS) ), ...
10-18 17:01